Back to top

vaccines: Archive

Zacks Equity Research

J&J (JNJ) Gets First Full Approval for COVID Jab in Canada

Canada grants full approval to J&J's (JNJ) COVID vaccine, making it the first full approval for the vaccine globally.

JNJNegative Net Change PFENegative Net Change MRNANegative Net Change BNTXNegative Net Change

Sweta Jaiswal, FRM

Will Pfizer ETFs Soar on Positive COVID-19 Vaccine Updates?

Here we highlight some ETFs with high exposure to Pfizer (PFE) that can gain from the encouraging updates in the coronavirus vaccine.

PFENegative Net Change PJPNegative Net Change IHENegative Net Change FDLNegative Net Change IEIHPositive Net Change BNTXNegative Net Change

Mark Vickery

FDA Authorizes Covid Boosters; New Fed Chair Soon?

Adults who receive booster vaccine shots will be much more highly immunized from Covid-19 than those simply "fully vaccinated."

PFENegative Net Change MRNANegative Net Change BNTXNegative Net Change

Zacks Equity Research

Novavax (NVAX) COVID Jab Gets Philippines Nod, Under Review in EU

Novavax's (NVAX) secures approval for its COVID vaccine in the Philippines. The EMA begins reviewing the company's regulatory submission for its COVID vaccine. Evidently, the stock gains.

GSKNegative Net Change NVAXNo Net Change SYBXNegative Net Change DTILPositive Net Change

Zacks Equity Research

Valneva (VALN) Stock Rises on Deal With EU for COVID-19 Jab

Valneva (VALN) enters into a supply agreement for its COVID vaccine candidate with the European Commission. The stock price surges following the news.

AZNPositive Net Change PFENegative Net Change MRNANegative Net Change VALNPositive Net Change